Safety and feasibility of granulocyte colony-stimulating factor (G-CSF) primed bone marrow (BM) using three days of G-CSF priming as stem cell source for pediatric allogeneic BM transplantation-Reference-Cited by-同舟云学术

Safety and feasibility of granulocyte colony-stimulating factor (G-CSF) primed bone marrow (BM) using three days of G-CSF priming as stem cell source for pediatric allogeneic BM transplantation

Published:2014-07-07 Issue:6 Volume:18 Page:625-630
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplantation

Author:

Hussein Ayad Ahmed¹,Sharma Shanta²,Al-Zaben Abdulhadi¹,Frangoul Haydar³

Affiliation:

1. Bone Marrow and Stem Cell Transplantation Program; King Hussein Cancer Center (KHCC); Amman Jordan

2. Department of Cellular Therapy and Applied Genomics; King Hussein Cancer Center (KHCC); Amman Jordan

3. Pediatric Stem Cell Transplant Program; Monroe Carell Jr. Children's Hospital at Vanderbilt; Nashville TN USA

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.12314/fullpdf

Reference25 articles.

1. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers;Bensinger;N Engl J Med,2001

2. Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis;Graf;Biol Blood Marrow Transplant,2001

3. HLA-identical stem cell transplantation: Is there an optimal CD34 cell dose?;Heimfeld;Bone Marrow Transplant,2003

4. Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells;Steidl;Blood,2002

5. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy;Weaver;Blood,1995

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells;Cytokine;2021-03

2. Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results;Biology of Blood and Marrow Transplantation;2019-05

3. Two versus three day upfront use of granulocyte-colony stimulating factor in healthy bone marrow donors for pediatric bone marrow transplantation;Transfusion and Apheresis Science;2017-12

4. Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors;Journal of Clinical Apheresis;2017-08-18

5. Hematopoietic stem cell transplantation from non-sibling matched family donors for patients with thalassemia major in Jordan;Pediatric Transplantation;2015-10-23